Versigent (NYSE:VGNT) Stock Rating Reaffirmed as Outperform by BNP Paribas Exane
Versigent (NYSE:VGNT – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at BNP Paribas Exane in a note issued to investors on Thursday, Benzinga reports. They presently have a $54.00 price target on the stock, down from their previous price target of $55.00. BNP Paribas Exane‘s price objective would indicate […]
7 Nov 17:01 · The Markets Daily